Research and Publication Ethics
JCS adheres to the guidelines and best practices published by professional organizations, including ICMJE Recommendations and the Principles of Transparency and Best Practice in Scholarly Publishing (https://doaj.org/bestpractice), and the Good Publication Practice Guideline for Medical Journals (https://www.kamje.or.kr/board/view?b_name=bo_publication&bo_id=13). Furthermore, all processes of handling research and publication misconduct (or when faced with cases of suspected misconduct) shall follow the applicable COPE flowchart (https://publicationethics.org/resources/flowcharts). Any attempts to duplicate publications or engage in plagiarism will lead to automatic rejection, may prejudice the acceptance of future submissions, and may be highlighted within the pages of the journal.
Clinical research should be conducted in accordance with the World Medical Association’s Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/). Clinical studies that do not meet the Declaration of Helsinki will not be considered for publication. For human subjects, identifiable information, such as patients’ names, initials, hospital numbers, dates of birth, or other protected healthcare information, should not be disclosed. For animal subjects, research should be performed based on the National or Institutional Guide for the Care and Use of Laboratory Animals, and the ethical treatment of all experimental animals should be maintained.
Copies of written informed consents should be kept for studies on human subjects. If the participant is not capable of providing it, a legal guardian, or parent can provide instead. For copies of informed consent, authors can submit the form used in their institutions or use the form provided by JCS. This form is available as a PDF at the JCS website or submission system. Scan the signed and completed form into your computer and then email it to us as an attachment when requested.
All clinical studies involving human participants should include a certificate, agreement, or approval from the Institutional Review Board (IRB). A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in all manuscripts reporting such research. For clinical studies with animal subjects, there should be a certificate, agreement, or approval from the Institutional Animal Care and Use Committee (IACUC). If necessary, the editor or reviewers may request copies of these documents to resolve questions about IRB/IACUC approval and study conduct.
All participants in the publication and peer review process—not only authors but also peer reviewers, editors, and Editorial Board members of the journal—must consider their conflicts of interest when fulfilling their roles in the process of article review and publication and must disclose all relationships that could be viewed as potential conflicts of interest. All authors should disclose their conflicts of interest, i.e., (1) financial relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony), (2) personal relationship, (3) academic competition, and (4) intellectual passion.
These conflicts of interest must be included as a footnote on the title page. Authors should certify the disclosure of any conflict of interest with their signatures. Peer reviewers must disclose to editors any conflicts of interest that could bias their opinions of the manuscript, and should recuse themselves from reviewing specific manuscripts if the potential for bias exists. Editors who make final decisions about manuscripts should recuse themselves from editorial decisions if they have conflicts of interest or relationships that pose potential conflicts related to articles under consideration. Other editorial staff members who participate in editorial decisions must provide editors with a current description of their financial interests or other conflicts (as they might relate to editorial judgments) and recuse themselves from any decisions in which a conflict of interest exists. Further guidance is available from COPE (http://www.icmje.org/recommendations/). If undisclosed conflict of interest is suspected in a submitted manuscript or published article, a committee composed of Editorial Board members will be held and discussed, and JCS will follow the process of the applicable COPE flowchart (https://publicationethics.org/resources/flowcharts).
According to the ICMJE recommendation, authorship credit should be based on the following four criteria: (1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation
of data for the work; AND (2) Drafting the work or revising it critically for important intellectual content; AND (3) Final approval of the version to be published; AND (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Authors should meet all four criteria.
• A list of each author’s role should accompany the submitted paper. The contributions of all authors must be described using the Contributor Roles Taxonomy (CRediT; https://credit.niso.org/).
• Correction of authorship: Any requests for such changes in authorship (adding author(s), removing author(s), or re-arranging the order of authors) after the initial manuscript submission and before publication should be explained in writing to the editor in a letter or email from all authors. This letter must be signed by all authors of the paper. Each author must complete the copyright assignment.
• Role of corresponding author: The corresponding author takes primary responsibility for communication with the journal during the manuscript submission, peer review, and publication process. The corresponding author typically ensures that all of the journal’s administrative requirements, such as providing the details of authorship, ethics committee approval, clinical trial registration documentation, and conflicts of interest forms and statements, are properly completed, although these duties may be delegated to one or more coauthors. The corresponding author should be available throughout the submission and peer review process to respond to editorial queries in a timely manner and after publication should be available to respond to critiques of the work and cooperate with any requests from the journal for data or additional information or questions about the article.
• Contributors: Any researcher who does not meet all four ICMJE criteria for authorship discussed above but contribute substantively to the study in terms of idea development, manuscript writing, conducting research, data analysis, and/or financial support should have their contributions listed in the Acknowledgments section of the article.
• Recommendations for working with people with personal connections: Authors who intend to include minors (under the age of 19) or their family members (such as spouse, children, and relatives) in their research, including when publishing or presenting papers jointly with them, should clearly indicate this in the cover letter. For further information, please refer to the "Guidelines for Preventing Illegitimate Authorship" by the National Research Foundation of Korea (https://www.cre.re.kr/).
Redundant or duplicate publication refers to the publication of a paper that overlaps substantially with one already published. Upon receipt, submitted manuscripts are screened for possible plagiarism or duplicate publication using Crossref Similarity Check. If a paper that might be regarded as duplicate or redundant had already been published in another journal or submitted for publication, the author should notify the fact in advance at the time of submission. Under these conditions, any such work should be referred to and referenced in the new paper. The new manuscript should be submitted together with copies of the duplicate or redundant material to the editorial committee. If redundant or duplicate publication is attempted or occurs without such notification, the submitted manuscript will be rejected immediately. If the editor was not aware of the violations and of the fact that the article had already been published, the editor will announce in the journal that the submitted manuscript had already been published in a duplicate or redundant manner, without seeking the author’s explanation or approval.
Secondary publication of material published in other journals or online may be justifiable and beneficial, especially when intended to disseminate important information to the widest possible audience (e.g., guidelines produced by government agencies and professional organizations in the same or a different language). Secondary publication may also be justifiable in conditions provided by ICMJE Recommendations (https://www.icmje.org/recommendations).
When the journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, a fraudulent undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, and complaints against editors, the resolution process will follow the flowchart provided by COPE (https://publicationethics.org/guidance/Flowcharts). The discussion and decision on the suspected cases are carried out by the Editorial Board.
The Editorial Board will continuously work to monitor and safeguard publication ethics: provision of guidelines for retracting articles; maintenance of the integrity of the academic record; preclusion of business needs from compromising intellectual and ethical standards; publication of corrections, clarifications, retractions, and apologies when needed; and exclusion of plagiarism and fraudulent data. The editors maintain the following responsibilities: responsibility and authority to reject and accept articles; confirmation of no conflict of interest with respect to articles they reject or accept; promotion of publication of corrections or retractions when errors are found; and preservation of the anonymity of reviewers.
Research Ethics Council is composed of a chairperson of the Publication Committee of the KTCVS and the members of the Committee. The Research Ethics Council is responsible for ensuring that research published in the JCS adheres to ethical standards. They review papers and investigate any issues found, reporting the results to the Board of Directors. The Council members also promote ethical practices by providing education for editors and authors.
In Seok Jeong, M.D. , Woong-Han Kim, M.D. , Jong Hyun Baek, M.D. , Chang-Hyu Choi, M.D. , Chang Woo Choi, M.D. , Euy Suk Chung, M.D. , Jae Seok Jang, M.D. , Woo Sung Jang, M.D. , Hanna Jung, M.D. , Jae-Seung Jung, M.D. , Pil Je Kang, M.D. , Dong Jung Kim, M.D. , Do Wan Kim, M.D. , Hyoung Soo Kim, M.D. , Jae Bum Kim, M.D. , Woo-Shik Kim, M.D. , Young Sam Kim, M.D. , Jae Gun Kwak, M.D. , Haeyoung Lee, M.D. , Seok In Lee, M.D. , Jae Woong Lim, M.D. , Se Jin Oh, M.D. , Tak-Hyuck Oh, M.D. , Chun Soo Park, M.D. , Kyoung Min Ryu, M.D. , Man-Shik Shim, M.D. , Joohyung Son, M.D. , Kuk Hui Son, M.D. , Seunghwan Song, M.D. , on behalf of The Korean Society for Thoracic and Cardiovascular Surgery COVID- ECMO Task Force Team
J Chest Surg 2021; 54(1): 2-8
Samina Park, M.D. , Yongwoo Chung, M.D. , Hyun Joo Lee, M.D. , In Kyu Park, M.D. , Chang Hyun Kang, M.D. , Young Tae Kim, M.D.
Korean J Thorac Cardiovasc Surg 2020; 53(3): 114-120
Sung-Jin Hong, M.D. , Jung-Sun Kim, M.D., Ph.D. , Geu-Ru Hong, M.D.
J Chest Surg 2021; 54(3): 165-171
Young Kern Kwon, M.D. , Sung Jun Park, M.D. , Suk Jung Choo, M.D., Ph.D. , Tae Jin Yun, M.D., Ph.D. , Jae Won Lee, M.D., Ph.D. , Joon Bum Kim, M.D., Ph.D.
Korean J Thorac Cardiovasc Surg 2020; 53(6): 346-352
Sang Pil Kim, M.D. , Juhyun Lee, M.D. , Sung Kwang Lee, M.D. , Do Hyung Kim, M.D.
J Chest Surg 2021; 54(3): 206-213
Hoyong Jun, M.D. , Saebeom Hur, M.D.
Korean J Thorac Cardiovasc Surg 2020; 53(4): 200-204